Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katja Thomas
Acute Effects of Alemtuzumab Infusion in Patients With Active Relapsing-Remitting MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Alemtuzumab in the Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis: An Update on the Clinical Trial Evidence and Data From the Real World
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Related publications
Endocarditis Following Ocrelizumab in Relapsing-Remitting MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Impact of Alemtuzumab on Health-Related Quality of Life Over 6 Years in CARE-MS II Trial Extension Patients With Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
Neurology
Natalizumab for Relapsing-Remitting Ms in the Uk Top Cohort
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Differential Reconstitution of T Cell Subsets Following Immunodepleting Treatment With Alemtuzumab (Anti-Cd52 Monoclonal Antibody) in Patients With Relapsing-Remitting Multiple Sclerosis
Journal of Immunology
Allergy
Immunology
Alemtuzumab: A Review of Efficacy and Risks in the Treatment of Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis
Arquivos de Neuro-Psiquiatria
Biological Psychiatry
Neurology
Antigen Specificity of Clonally Expanded and Receptor Edited Cerebrospinal Fluid B Cells From Patients With Relapsing Remitting MS
Journal of Neuroimmunology
Allergy
Immunology
Neurology
Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis
Archives of Neurology